孟加拉国与暴露相关的高血压和循环氧化生物利用率的降低
Moriom Khatun1, Nazmul Haque1, Abu Eabrahim Siddique2
1Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, Bangladesh.
Environmental health perspectives
|April 4, 2024
概括
暴露会增加高血压风险,其中氧化 (NO) 的生物可用性降低是关键机制. 这项在孟加拉国的研究将更高的含量与高血压和高血压联系起来,而高血压和高血压是由受损的NO功能介导的.
科学领域:
- 环境健康 环境健康
- 心血管疾病流行病学
- 毒理学 毒理学 毒理学
背景情况:
- 高血压是全球主要的死亡原因.
- 暴露与高血压有关,但结果在不同人群中不一致.
- 血管氧化 (NO) 生物可用性受损是高血压的潜在机制.
研究的目的:
- 为了研究暴露和高血压之间的剂量反应关系.
- 评估血管NO水平在相关高血压中的调解作用.
主要方法:
- 招募了来自孟加拉国的828名参与者,他们的暴露水平各不相同.
- 测量了饮用水,头发和指甲中的含量.
- 评估了高血压,血压 (SBP/DBP) 和血清酸盐 (NO标志物);进行了因果调解分析.
主要成果:
- 水,头发和指甲中的度增加与较高的SBP和DBP相关.
- 暴露显示了高血压几率的剂量依赖性增加,即使在中等水平.
- 因果调解分析证实,NO显著调解暴露与高血压之间的关联.
结论:
- 较高的暴露与高血压风险增加有关.
- 血管NO生物可用性降低是引起的高血压的潜在机制.
- 研究结果强调了污染对孟加拉国心血管健康的公共卫生影响.
相关概念视频
Antihypertensive Drugs: Vasodilators
516
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
516
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Antianginal Drugs: Nitrates and β-Blockers
580
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
580
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
627
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
627
Types of Toxins
1.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
159
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
159


